- Home
- DCTH vs JGH Comparison
DCTH vs JGH Comparison
Compare DCTH & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- JGH
- Stock Information
- Founded
- DCTH 1988
- JGH 2014
- Country
- DCTH United States
- JGH United States
- Employees
- DCTH N/A
- JGH N/A
- Industry
- DCTH Medical/Dental Instruments
- JGH Investment Managers
- Sector
- DCTH Health Care
- JGH Finance
- Exchange
- DCTH Nasdaq
- JGH Nasdaq
- Market Cap
- DCTH 630.4M
- JGH 292.3M
- IPO Year
- DCTH N/A
- JGH N/A
- Fundamental
- Price
- DCTH $13.57
- JGH $12.77
- Analyst Decision
- DCTH Strong Buy
- JGH
- Analyst Count
- DCTH 4
- JGH 0
- Target Price
- DCTH $24.00
- JGH N/A
- AVG Volume (30 Days)
- DCTH 734.6K
- JGH 73.9K
- Earning Date
- DCTH 08-04-2025
- JGH 01-01-0001
- Dividend Yield
- DCTH N/A
- JGH 9.85%
- EPS Growth
- DCTH N/A
- JGH N/A
- EPS
- DCTH N/A
- JGH N/A
- Revenue
- DCTH $53,850,000.00
- JGH N/A
- Revenue This Year
- DCTH $155.42
- JGH N/A
- Revenue Next Year
- DCTH $37.93
- JGH N/A
- P/E Ratio
- DCTH N/A
- JGH N/A
- Revenue Growth
- DCTH 1068.87
- JGH N/A
- 52 Week Low
- DCTH $7.17
- JGH $10.36
- 52 Week High
- DCTH $18.23
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- DCTH 38.26
- JGH 60.69
- Support Level
- DCTH $12.98
- JGH $12.53
- Resistance Level
- DCTH $14.18
- JGH $12.81
- Average True Range (ATR)
- DCTH 0.68
- JGH 0.10
- MACD
- DCTH -0.28
- JGH -0.01
- Stochastic Oscillator
- DCTH 15.95
- JGH 76.56
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.